The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > ARCHIVE
ARCHIVE
- Most Doctors Expect Effective Drugs Will Be Needed for AIDS in 2001: JHSF Survey
April 23, 2001
- Hisamitsu Forms Genofunctionfor Genome-related Business
April 23, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
April 23, 2001
- Keidanren, Nikkeiren to Discuss Healthcare System for Elderly
April 23, 2001
- WORLD NEWS IN BRIEF
April 23, 2001
- BUSINESS NEWS IN BRIEF -1-
April 23, 2001
- Hac Kimisawa to Open Record-high Number of New Stores
April 23, 2001
- Kokuho Balance of Payment Records Deficit of \120.8 Bil. in FY1999
April 16, 2001
- Sun Drug, Kawachi Yakuhin to Remain Highly Profitable: Nomura Report
April 16, 2001
- Grand Design for Social Security Reform Announced by Gov't, Ruling Coalition
April 16, 2001
- Jovi, Wing to Merge on October 1
April 16, 2001
- 15 New Active Ingredients Including Gemzar, Zyvox Approved
April 16, 2001
- Kirin-do: Double-digit Increases in Sales, Profits
April 16, 2001
- Criteria for Disclosure, Non-disclosure Published
April 16, 2001
- MEDICAL DEVICE NEWS IN BRIEF
April 16, 2001
- Hitachi, Myriad, Oracle, Friedli to Tie Up in Proteomics
April 16, 2001
- JPA Leader Comments on New Deregulation Promotion Plan
April 16, 2001
- Sankyo to Be Aggressive in Genomic Drug Discovery: Dr Hiraoka
April 16, 2001
- Toyama to Exclusively Market YP-14 Jointly Developed with Taiho
April 16, 2001
- Review of NHI Price System Included in New Deregulation Plan
April 16, 2001
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…